References: Overview of inflammatory connective tissue diseases

  • Australian Rheumatology Association (ARA). Recommendation 2: Do not order antinuclear antibody (ANA) testing without symptoms and/or signs suggestive of a systemic rheumatic disease. Sydney: Choosing Wisely Australia; 2018. Accessed Dec 2022. https://www.choosingwisely.org.au/recommendations/ara2
  • Australian Rheumatology Association (ARA). Recommendation 5. Do not order anti-double stranded (ds) DNA antibodies in ANA negative patients unless clinical suspicion of systemic lupus erythematosus (SLE) remains high. Sydney: Choosing Wisely Australia. 2018; Updated 06 Feb 2018. Accessed 05 Jan 2022. https://www.choosingwisely.org.au/recommendations/ara5
  • Nashi RA, Shmerling RH. Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus. Medical Clinics North America 2021;105(2):387-96. https://www.ncbi.nlm.nih.gov/pubmed/33589110
  • Pons-Estel GJ, Andreoli L, Scanzi F, Cervera R, Tincani A. The antiphospholipid syndrome in patients with systemic lupus erythematosus. Journal of Autoimmunity 2017;76:10-20. https://www.ncbi.nlm.nih.gov/pubmed/27776934
  • Selmi C, Ceribelli A, Generali E, Scire CA, Alborghetti F, Colloredo G, et al. Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years. Autoimmunity Reviews 2016;15(2):162-6. https://www.ncbi.nlm.nih.gov/pubmed/26524640